Bioventix (GB:BVXP) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Bioventix PLC has released its Annual Report for the year ending June 2024 and announced its upcoming Annual General Meeting on December 5th. The company, known for its high-affinity monoclonal antibodies used in clinical diagnostics, continues to supply a wide range of antibodies to multinational diagnostics firms. Investors can access these documents through the company’s website to stay informed about its financial performance and strategic direction.
For further insights into GB:BVXP stock, check out TipRanks’ Stock Analysis page.